Education
About Us
Working with TipRanks
Follow Us
Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
Total Valuation
Krebs Biochemicals & Industries Ltd. has a market cap or net worth of ₹1.82B. The enterprise value is ₹2.21B.
Market Cap₹1.82B
Enterprise Value₹2.21B
Share Statistics
Krebs Biochemicals & Industries Ltd. has 21,560,587 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,560,587
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Krebs Biochemicals & Industries Ltd.’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is -18.66%.
Return on Equity (ROE)0.18
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-18.66%
Return on Capital Employed (ROCE)-0.33
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.26
Inventory Turnover0.92
Valuation Ratios
The current PE Ratio of Krebs Biochemicals & Industries Ltd. is 0.00. Krebs Biochemicals & Industries Ltd.’s PEG ratio is -0.16.
PE Ratio0.00
PS Ratio0.00
PB Ratio-4.11
Price to Fair Value0.00
Price to FCF-7.57
Price to Operating Cash Flow-17.91
PEG Ratio-0.16
Income Statement
In the last 12 months, Krebs Biochemicals & Industries Ltd. had revenue of 433.12M and earned -269.39M in profits. Earnings per share was 0.00.
Revenue433.12M
Gross Profit377.56M
Operating Income-217.19M
Pretax Income-269.24M
Net Income-269.39M
EBITDA-143.21M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Krebs Biochemicals & Industries Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.16
52-Week Price Change24.77%
50-Day Moving Average79.81
200-Day Moving Average86.42
Relative Strength Index (RSI)53.50
Average Volume (3m)4.36K
Important Dates
Krebs Biochemicals & Industries Ltd. upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 20, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
Krebs Biochemicals & Industries Ltd. as a current ratio of 0.10, with Debt / Equity ratio of -77.37%
Current Ratio0.10
Quick Ratio0.04
Debt to Market Cap0.00
Net Debt to EBITDA-14.81
Interest Coverage Ratio-3.67
Taxes
In the past 12 months, Krebs Biochemicals & Industries Ltd. has paid 153.00K in taxes.
Income Tax153.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Krebs Biochemicals & Industries Ltd. EV to EBITDA ratio is -14.81, with an EV/FCF ratio of -18.51.
EV to Sales4.90
EV to EBITDA-14.81
EV to Free Cash Flow-18.51
EV to Operating Cash Flow-26.87
Balance Sheet
Krebs Biochemicals & Industries Ltd. has ₹3.38M in cash and marketable securities with ₹2.12B in debt, giving a net cash position of ₹2.12B billion.
Cash & Marketable Securities₹3.38M
Total Debt₹2.12B
Net Cash₹2.12B
Net Cash Per Share₹98.27
Tangible Book Value Per Share₹0.00
Margins
Gross margin is -39.21%, with operating margin of -50.15%, and net profit margin of -62.20%.
Gross Margin-39.21%
Operating Margin-50.15%
Pretax Margin-62.16%
Net Profit Margin-62.20%
EBITDA Margin-33.06%
EBIT Margin-48.51%
Analyst Forecast
The average price target for Krebs Biochemicals & Industries Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―